Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Diazepam"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringDiazepam
brandStringValium (oral, IV/IM, rectal), Diastat (rectal gel for breakthrough seizures), Valtoco (nasal spray for breakthrough seizures), Libervant (buccal film)
structureFile
classesList of String, delimiter: ,[[:Category:Benzodiazepines|Benzodiazepine (long-acting)]] [[:Category:Anxiolytics|Anxiolytic]] [[:Category:Anticonvulsants|Anticonvulsant]] [[:Category:Skeletal muscle relaxants|Skeletal muscle relaxant]] [[:Category:Schedule IV controlled substances|Schedule IV controlled substance]]
mechanismString
usesString'"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"'
starting_doseStringAnxiety: 2-10 mg PO 2-4 times daily. Alcohol withdrawal: 10-20 mg PO/IV every 4-6 hours, symptom-triggered. Status epilepticus: 5-10 mg IV. Breakthrough seizures: Diastat rectal 0.2-0.5 mg/kg or Valtoco intranasal 5-20 mg
preparationsStringTablets 2, 5, 10 mg; oral solution 1, 5 mg/mL; injection 5 mg/mL; Diastat rectal gel 2.5, 5, 10, 20 mg; Valtoco nasal spray 5, 7.5, 10 mg/dose; Libervant buccal film
fda_maxString40 mg/day (oral, anxiety)
pill_idText
routesList of String, delimiter: ,Oral IV IM rectal intranasal buccal
onsetString15-60 minutes (oral); 1-5 minutes (IV); 4-10 minutes (rectal or intranasal)
durationString6-24 hours (parent); much longer when accounting for the long-lived active metabolites
halflifeStringDiazepam 20-50 hours; '''N-desmethyldiazepam (nordazepam) 30-200 hours''' is the major active metabolite and accumulates substantially with chronic dosing'"`UNIQ--ref-00000026-QINU`"'
bioavailabilityString~93% (oral); ~90% (rectal)'"`UNIQ--ref-00000027-QINU`"'
pregnancyStringSome signal for cleft palate with first-trimester exposure (debated); neonatal sedation and withdrawal with third-trimester exposure.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Schedule IV|Schedule IV controlled substance]] in US. Carries the benzodiazepine class '''Boxed Warning''' for risk of fatal respiratory depression, coma, and death when combined with opioids'"`UNIQ--ref-00000028-QINU`"'